Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.trstmh.2009.01.020 | DOI Listing |
Philos Trans R Soc Lond B Biol Sci
January 2025
Senior Commissioning Editor, Philosophical Transactions B, The Royal Society, London, UK.
J Psychoactive Drugs
January 2025
Global Health Policy and Data Institute, San Diego, CA, USA.
Growing cannabis use has made it the most widely cultivated and trafficked illicit drug globally according to the World Health Organization, with 147 million people consuming cannabis-derived products (CDPs) in various product forms and constituency. Despite restrictions in certain countries, unregulated access can still be found on the dark web which specializes in trafficking of illicit goods. The objective was to systematically collect data from multiple marketplaces to identify types of cannabis products offered for sale.
View Article and Find Full Text PDFPhilos Trans A Math Phys Eng Sci
December 2024
Max-Planck-Institute for Sustainable Materials, Düsseldorf 40237, Germany.
This article introduces a special issue of the transactions arising from a Royal Society Discussion Meeting on 'sustainable metals'. Recognizing that progress to date toward the goals of 'sustainability' has been limited, the meeting aimed to open up a new level of interdisciplinary dialogue, collaboration and discussion of disruptive approaches. In this paper, the major concerns of sustainability are enumerated, and climate change is identified as the most urgent.
View Article and Find Full Text PDFBr J Health Psychol
February 2025
Department of Psychology, The University of Sheffield, Sheffield, UK.
Cureus
May 2024
Institute of Comparative Economic Studies, Hosei University, Tokyo, JPN.
Both public and academic scrutiny of the financial relationships between the medical device industry and the healthcare society occur less frequently than those involving the pharmaceutical industry, and Japan is no exception to these shortcomings. This paper examines the ethical and legal challenges inherent in Japan's medical device industry through the lens of bribery scandals, placing these issues within the broader context of global healthcare corruption. It aims to derive lessons and suggest universal strategies for ethical and legal enhancements.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!